Aethoxysklerol International

Kreussler Pharma is a specialized German pharmaceutical company and a global leader in the field of sclerotherapy. The company's primary product is Aethoxysklerol (polidocanol), a sclerosing agent used for the treatment of varicose veins and hemorrhoids, which is marketed in over 50 countries. In the United States, the product is FDA-approved and marketed under the brand name Asclera through a partnership with Merz. Beyond phlebology, Kreussler Pharma also develops and manufactures products for proctology and oral medicine, including the pain-relief brand Dynexan. Founded in 1912 and based in Wiesbaden, Germany, the company is a division of the family-owned Chemische Fabrik Kreussler & Co. GmbH.